文献速递眼底病与葡萄膜炎

数字化正念干预对非感染性葡萄膜炎患者心理健康与视相关生活质量的影响

The Effects of a Digital Mindfulness Intervention on Mental Health and Vision-Related Quality of Life in Noninfectious Uveitis.
PubMed 文献 · Ophthalmology · 2026-06-15

一项单中心、单盲、等待列表对照的随机临床试验纳入100例伴有轻度及以上焦虑或抑郁的非感染性葡萄膜炎成人患者,评估数字化正念项目(Calm Health)对心理健康结局的影响。8周后,干预组GAD-7评分显著低于对照组(均差-1.7分,95%CI -3.17至-0.23,P=0.02),PHQ-9和PSS-10评分亦显著改善,但NEI VFQ-25变化无统计学意义。

要点

  • 数字化正念干预可显著降低非感染性葡萄膜炎患者的焦虑、抑郁和感知压力。
  • 视相关生活质量(NEI VFQ-25)在干预组与对照组间无显著差异。
  • 该工具或可作为葡萄膜炎护理的可行、可扩展辅助手段。

核心结论

  • 数字化正念干预(Calm Health)显著降低非感染性葡萄膜炎成人的焦虑、抑郁和感知压力。
  • 数字化正念工具可能作为葡萄膜炎护理的可行、可扩展辅助手段,尤其在传统心理健康服务可及性有限的环境中。

研究设计与样本

  • 单中心、单盲、等待列表对照的随机临床试验。
  • 纳入100例年龄≥18岁、患有活动性或非活动性非感染性葡萄膜炎且基线伴有轻度或以上焦虑或抑郁的成人,按1:1随机分配至立即使用正念应用程序(Calm Health)组或等待列表对照组。
  • 干预组被指导每日使用Calm Health移动应用程序≥10分钟,持续8周;对照组在此期间不接受新的正念干预。
  • 结局在基线和8周时通过经验证的问卷评估。

主要发现

  • 100例随机参与者(中位年龄43.5岁;75%女性)中,70例完成主要终点评估。
  • 干预组参与者8周内应用程序使用时间中位数[Q1,Q3]为578.62[397.79,923.00]分钟。
  • 调整基线评分后,干预组8周时GAD-7评分显著低于对照组(均差-1.7分;95%CI -3.17至-0.23,P=0.02)。
  • 次要分析显示干预组PHQ-9评分(-1.90分;95%CI -3.04至-0.76,P=0.001)和PSS-10评分(-3.69分;95%CI -6.00至-1.37,P=0.002)下降显著大于对照组。
  • NEI VFQ-25评分组间变化无统计学意义(均差1.98分;95%CI -0.90至4.86,P=0.18)。

关键数值与推荐

  • 主要结局为8周时广泛性焦虑障碍-7(GAD-7)测量的焦虑症状严重程度评分的均差。
  • 次要结局包括抑郁(患者健康问卷-9[PHQ-9])、感知压力(感知压力量表-10[PSS-10])和视相关生活质量(国家眼科研究所视觉功能问卷-25[NEI VFQ-25])的变化。
  • 结局使用线性协方差分析(ANCOVA)模型分析,调整基线评分。

临床怎么用

  • 对于伴有轻度或以上焦虑或抑郁的非感染性葡萄膜炎成人患者,可考虑推荐数字化正念项目作为辅助干预以改善心理健康。
  • 数字化正念工具可能尤其适用于传统心理健康服务可及性有限的环境。
  • 该干预对视相关生活质量的改善尚未证实,需结合其他措施管理视功能相关问题。

局限性

  • 单中心设计可能限制结果的外推性。
  • 100例随机参与者中仅70例完成主要终点评估,存在缺失数据。
  • 干预组应用程序使用时间中位数约为578.62分钟/8周,依从性存在个体差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the effect of a digital mindfulness-based program (Calm Health) on mental health outcomes in adults with noninfectious uveitis (NIU). DESIGN: Single-center, single-masked, waitlist-controlled, randomized clinical trial. PARTICIPANTS: One hundred adults aged ≥18 years with active or inactive NIU and baseline mild or greater anxiety or depression were randomized 1:1 to immediate access to a mindfulness application (app) (Calm Health) or to a waitlist control group. METHODS: Participants in the intervention group were instructed to use the Calm Health mobile app for ≥10 minutes daily for 8 weeks. Controls received no new mindfulness intervention during this period. Outcomes were assessed at baseline and 8 weeks using validated surveys. MAIN OUTCOME MEASURES: The primary outcome was the mean difference in the anxiety symptom severity score measured by the Generalized Anxiety Disorder-7 (GAD-7) at 8 weeks. Secondary outcomes included changes in depression (Patient Health Questionnaire-9 [PHQ-9]), perceived stress (Perceived Stress Scale-10 [PSS-10]), and vision-related quality of life (National Eye Institute Visual Function Questionnaire-25 [NEI VFQ-25]). Outcomes were analyzed using linear analysis of covariance (ANCOVA) models, adjusting for baseline scores. RESULTS: Of 100 randomized participants (median age 43.5 years; 75% female), 70 completed the primary endpoint assessment. Median [Q1, Q3] total app use among intervention participants was 578.62 [397.79, 923.00] minutes over 8 weeks. After adjustment for baseline scores, the intervention group had a significantly lower GAD-7 score at 8 weeks compared with controls (mean difference -1.7 points; 95% CI, -3.17 to -0.23, P = 0.02). Secondary analyses showed significantly greater reductions in PHQ-9 scores (-1.90 points; 95% CI, -3.04 to -0.76, P = 0.001) and PSS-10 scores (-3.69 points; 95% CI, -6.00 to -1.37, P = 0.002) in the intervention group. Changes in NEI VFQ-25 scores were not statistically significant between groups (mean difference 1.98 points; 95% CI, -0.90 to 4.86, P = 0.18). Sensitivity analyses accounting for missing data and clinical covariates yielded similar results. CONCLUSIONS: A digital mindfulness-based intervention (Calm Health) significantly reduced anxiety, depression, and perceived stress in adults with NIU. Digital mindfulness tools may serve as a feasible, scalable adjunct to uveitis care, particularly in settings with limited access to traditional mental health services. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Shantha JG, Ray I, Kumar A, et al. The Effects of a Digital Mindfulness Intervention on Mental Health and Vision-Related Quality of Life in Noninfectious Uveitis. Ophthalmology. 2026. PMID: 42297306. doi:10.1016/j.ophtha.2026.06.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。